-
Loading metrics
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
- Srilekha Sridhara,
- Ahmet B. Gungor,
- Halil K. Erol,
- Mohanad Al-Obaidi,
- Tirdad T. Zangeneh,
- Edward J. Bedrick,
- Venkatesh K. Ariyamuthu,
- Aneesha Shetty,
- Abd A. Qannus,
- Katherine Mendoza
![PLOS](/resource/img/logo-plos.png)
x
- Published: April 28, 2023
- https://doi.org/10.1371/journal.pone.0279326